TANG CAPITAL MANAGEMENT, LLC 13D and 13G filings for CytomX Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | TANG CAPITAL MANAGEMENT, LLC | 0 0.000% | -11,065,662 (Position Closed) | Filing |
| 2025-08-14 4:15 pm Purchase | 2025-06-30 | 13G | CytomX Therapeutics, Inc. CTMX | TANG CAPITAL MANAGEMENT, LLC | 11,065,662 7.000% | 4,347,837 (+64.72%) | Filing |
| 2025-05-15 4:15 pm Sale | 2025-03-31 | 13G | CytomX Therapeutics, Inc. CTMX | TANG CAPITAL MANAGEMENT, LLC | 6,717,825 8.400% | -1,093,935 (-14.00%) | Filing |
| 2024-11-14 4:00 pm Purchase | 2024-09-30 | 13G | CytomX Therapeutics, Inc. CTMX | TANG CAPITAL MANAGEMENT, LLC | 7,811,760 9.990% | 7,811,760 (New Position) | Filing |